EuBiologics receives funding from the RIGHT Fund for the development of a cholera conjugate vaccine

      July 25, 2019 – SEOUL, South Korea. The International Vaccine Institute (IVI) is pleased to announce that EuBiologics, IVI’s key partner in Korea, received a 900 million Korean won ($760,000) award from the RIGHT Fund for the development of a cholera conjugate […]

IVI, KSC hold donation ceremony for Raphas

Raphas committed to increase contributions to IVI through ‘Giving Vaccine’ campaign   From left to right: Francois Belin, COO of IVI; Prof. Park Sang-chul, President of the Korea Support Committee for IVI; Dr. DoHyeon Jeong, CEO of Raphas   July 25, 2019 – SEOUL, South […]

Present and Future of Vaccine Development’ seminar series: Improved vaccine for foot-and-mouth-disease control

July 26, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Doctor of Veterinary Medicine (DVM), Jong-Hyeon Park, PhD., Head of the Center for FMD Vaccine Research Animal and Plant Quarantine Agency. He […]

IVI teams up with 4 Korean partners to nurture vaccine industry professionals

Representatives from five organizations, including IVI Director General Dr. Jerome Kim (second from left), pose for a commemorative photo as they exchange an MOU on the development of human resources and vaccine technology and industry at Andong National University in Gyeongsangbuk-do Province, Korea on July […]